Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer

Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer

Item
http://www.wikidata.org/entity/Q34796364
Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETPET imaging of early response to the tyrosine kinase inhibitor ZD4190.Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer.Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: 18F-FAU, 18F-FMAU, and 18F-FLT.Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone.FLT PET-CT in evaluation of treatment response.Radiopharmaceuticals as probes to characterize tumour tissue.18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture.Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis.A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.Utilizing radiolabeled 3'-deoxy-3'-[18F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.
P2860

Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer

Item
http://www.wikidata.org/entity/Q34796364
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Analysis and reproducibility o ...... ith non-small cell lung cancer
@ast
Analysis and reproducibility o ...... ith non-small cell lung cancer
@en
Analysis and reproducibility o ...... ith non-small cell lung cancer
@nl
type
label
Analysis and reproducibility o ...... ith non-small cell lung cancer
@ast
Analysis and reproducibility o ...... ith non-small cell lung cancer
@en
Analysis and reproducibility o ...... ith non-small cell lung cancer
@nl
prefLabel
Analysis and reproducibility o ...... ith non-small cell lung cancer
@ast
Analysis and reproducibility o ...... ith non-small cell lung cancer
@en
Analysis and reproducibility o ...... ith non-small cell lung cancer
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Analysis and reproducibility o ...... ith non-small cell lung cancer
@en
P2093
P2860
P304
P31
P356
10.1158/1078-0432.CCR-07-5243
P407
P433
P478
P577
P698
P921
P932